Literature DB >> 19003906

Reversible posterior leuko-encephalopathy in children with sickle cell disease.

Zarir Khademian1, Barbara Speller-Brown, Seyed-Medhi Nouraie, Caterina P Minniti.   

Abstract

Children with sickle cell disease (SCD) have high risk of neurologic morbidity and mortality, such as strokes, silent infarcts and TIA's. A retrospective review of magnetic resonance imaging and magnetic resonance angiography identified eight children with radiological and clinical characteristics of reversible posterior encephalopathy (RPLS). These patients had no evidence of previous cerebral infarcts or vasculopathy. Three have died during the 5-year follow up; one developed a stroke and one a conditional TCD. RPLS needs to be considered in the differential diagnosis of children with SCD that present with acute neurological changes, especially if they are already been hospitalized.

Entities:  

Mesh:

Year:  2009        PMID: 19003906     DOI: 10.1002/pbc.21812

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

Review 1.  Neuroimaging findings in sickle cell disease.

Authors:  S C Thust; C Burke; A Siddiqui
Journal:  Br J Radiol       Date:  2014-05-21       Impact factor: 3.039

Review 2.  Headache and Facial Pain in Sickle Cell Disease.

Authors:  Angeliki Vgontzas; Larry Charleston; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2016-03

3.  MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.

Authors:  Eyal Muscal; Elfrides Traipe; Marietta M de Guzman; Barry L Myones; Robin L Brey; Jill V Hunter
Journal:  Pediatr Radiol       Date:  2010-01-30

4.  A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Authors:  Shalini Shenoy; Mary Eapen; Julie A Panepinto; Brent R Logan; Juan Wu; Allistair Abraham; Joel Brochstein; Sonali Chaudhury; Kamar Godder; Ann E Haight; Kimberly A Kasow; Kathryn Leung; Martin Andreansky; Monica Bhatia; Jignesh Dalal; Hilary Haines; Jennifer Jaroscak; Hillard M Lazarus; John E Levine; Lakshmanan Krishnamurti; David Margolis; Gail C Megason; Lolie C Yu; Michael A Pulsipher; Iris Gersten; Nancy DiFronzo; Mary M Horowitz; Mark C Walters; Naynesh Kamani
Journal:  Blood       Date:  2016-09-13       Impact factor: 22.113

5.  Uncommon Posterior Reversible Encephalopathy Syndrome in a Sickle-Cell Patient.

Authors:  Anne Landais; Nathalie Lemonne; Maryse Etienne-Julan
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

6.  Acute Hemorrhagic Encephalitis Responding to Combined Decompressive Craniectomy, Intravenous Immunoglobulin, and Corticosteroid Therapies: Association with Novel RANBP2 Variant.

Authors:  Abdulla Alawadhi; Christine Saint-Martin; Farhan Bhanji; Myriam Srour; Jeffrey Atkinson; Guillaume Sébire
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

7.  Radiological findings of Posterior Reversible Encephalopathy Syndrome in transplanted children previous affected by hemoglobinopathy: A neuroimaging retrospective analysis.

Authors:  Eliseo Picchi; Francesca Di Giuliano; Simone Marziali; Silvia Minosse; Valentina Ferrazzoli; Valerio Da Ros; Javid Gaziev; Chiara Adriana Pistolese; Roberto Floris; Francesco Garaci
Journal:  Eur J Radiol Open       Date:  2019-04-16

Review 8.  Posterior Reversible Encephalopathy Syndrome.

Authors:  Alexandra N Gewirtz; Virginia Gao; Sarah C Parauda; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2021-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.